Study of high-dose Pitavastatin on lipid and glucose metabolism disorder in Coronary Artery Disease. (Shield-CAD) - Study of high-dose Pitavastatin on lipid and glucose metabolism disorder in Coronary Artery Disease. (Shield-CAD)

Minami-Osaka Hospital0 个研究点目标入组 100 人开始时间: 2012年8月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Exclusion Criteria 1. Patients planed revascularization 2. Patients with occurrence of acute coronary syndrome (AMI or Unstable angina) within 3 months 3. Patients who have been undergone PCI or CABG within 3 months 4. Malignant tumor in active phase 5. Patients who have hypersensitivity to LIVALO, Lipitor, CRESTOR tablet 6) Patients who have severe liver dysfunction or biliary atresia. 7)Patients who are being treated with cyclosporine 8) Pregnant women, women suspected of being pregnant, or lactating women 9. Patients with prohibited drugs 10. Patients who received insulin therapy. 11. Patients who changed diabetes therapy within 3 months before entry. 12. Patients who received cholesterol-lowering agents except statin within a month before entry. 13. Patients undergoing dialysis 14. Patients with familial hypercholesterolemia 15. Patients who are ineligible in the opinion of the investigator

发起方

Minami-Osaka Hospital